IDXX
IDEXX Laboratories, Inc.
Price Chart
Latest Quote
$554.94
+5.78 (+1.05%)
Current Price
| Previous Close | $549.16 |
| Open | $549.99 |
| Day High | $570.84 |
| Day Low | $545.66 |
| Volume | 617,152 |
Stock Information
| Shares Outstanding | 78.88M |
| Total Debt | $1.11B |
| Cash Equivalents | $200.53M |
| Revenue | $4.45B |
| Net Income | $1.10B |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $43.78B |
| P/E Ratio | 40.80 |
| EPS (TTM) | $13.60 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $44.68B |
| Sales | $4.45B |
| Income | $1.10B |
| Book/sh | $19.64 |
| Cash/sh | $2.54 |
| Employees | 11K |
Financial Ratios
| Quick Ratio | 0.69 |
| Current Ratio | 1.12 |
| Debt/Eq | 71.04 |
| EPS Growth TTM | 14.70% |
Returns & Margins
| ROA | 26.46% |
| ROE | 72.91% |
| Gross Margin | 62.05% |
| Operating Margin | 31.78% |
| Profit Margin | 24.63% |
Ownership
| Insider Ownership | 0.22% |
| Institutional Ownership | 96.18% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 33.60 |
| PEG | 3.52 |
| P/S | 9.85 |
| P/B | 28.26 |
Analyst Data
| Recommendation | none |
| Target Price | $709.14 |
Technical Indicators
| SMA20 | $559.75 |
| SMA50 | $559.55 |
| SMA200 | $630.62 |
| RSI | 46.41 |
| ATR | 17.1200 |
| Shares Float | 78.58M |
| Short Float | 3.10% |
| Short Ratio | 3.47 |
| Volatility | 1.54 |
| Rel Volume | 0.94 |
Performance History
| Week | +1.62% |
| Month | -0.41% |
| Quarter | -3.61% |
| 6 Months | -20.96% |
| YTD | -17.17% |
| Year | +4.61% |
| 3 Years | +15.08% |
| 5 Years | -8.15% |
| 10 Years | +540.66% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $554.94 | 628,900 |
| 2026-06-24 | $549.16 | 643,200 |
| 2026-06-23 | $541.31 | 652,200 |
| 2026-06-22 | $545.73 | 627,600 |
| 2026-06-18 | $562.09 | 1,240,800 |
| 2026-06-17 | $546.09 | 619,400 |
| 2026-06-16 | $573.00 | 498,700 |
| 2026-06-15 | $570.00 | 556,800 |
| 2026-06-12 | $560.88 | 516,600 |
| 2026-06-11 | $557.91 | 612,200 |
| 2026-06-10 | $556.94 | 591,800 |
| 2026-06-09 | $578.89 | 452,300 |
| 2026-06-08 | $561.17 | 370,500 |
| 2026-06-05 | $562.16 | 459,100 |
| 2026-06-04 | $564.74 | 631,300 |
| 2026-06-03 | $560.73 | 891,300 |
| 2026-06-02 | $550.82 | 669,100 |
| 2026-06-01 | $566.79 | 604,400 |
| 2026-05-29 | $563.53 | 1,417,100 |
| 2026-05-28 | $568.03 | 725,800 |
| 2026-05-27 | $550.99 | 504,700 |
| 2026-05-26 | $557.21 | 425,100 |
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
đ° Latest News
A Small Upgrade Could Have a Big Impact for IDEXX Customers
Insider Monkey âĸ 2026-06-22T13:31:12Z
Is IDEXX Laboratories Stock Underperforming the Nasdaq?
Barchart âĸ 2026-06-09T12:42:40Z
Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound?
Zacks âĸ 2026-06-04T15:30:17Z
IDEXX Parasite Test Expansion Links Zoonotic Risk And Valuation Debate
Simply Wall St. âĸ 2026-06-03T21:19:54Z
IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference
MarketBeat âĸ 2026-05-30T11:02:23Z
IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test Profile
Insider Monkey âĸ 2026-05-27T21:56:21Z
Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock?
Barchart âĸ 2026-05-26T12:05:16Z
Should IDEXXâs (IDXX) SDMA-Enhanced Catalyst Panels Prompt Action From Long-Term Diagnostics Investors?
Simply Wall St. âĸ 2026-05-20T12:06:32Z
Do You Believe in the Long-Term Growth Potential of IDEXX Laboratories (IDXX)?
Insider Monkey âĸ 2026-05-14T14:39:33Z
BofA Sees Slower InVue Installations as Headwind for IDEXX Laboratories, Inc. (IDXX)
Insider Monkey âĸ 2026-05-11T20:01:23Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,644,123,000 | $1,518,577,000 | $1,470,983,000 | $1,362,986,000 |
| Cost Of Revenue | $1,644,123,000 | $1,518,577,000 | $1,470,983,000 | $1,362,986,000 |
| Total Revenue | $4,303,702,000 | $3,897,504,000 | $3,660,953,000 | $3,367,324,000 |
| Operating Revenue | $4,303,702,000 | $3,897,504,000 | $3,660,953,000 | $3,367,324,000 |
| Expenses | ||||
| Interest Expense | $38,852,000 | $31,205,000 | $41,581,000 | $39,858,000 |
| Total Expenses | $2,943,671,000 | $2,769,167,000 | $2,563,825,000 | $2,468,559,000 |
| Net Non Operating Interest Income Expense | $-35,842,000 | $-18,506,000 | $-35,952,000 | $-38,793,000 |
| Interest Expense Non Operating | $38,852,000 | $31,205,000 | $41,581,000 | $39,858,000 |
| Operating Expense | $1,299,548,000 | $1,250,590,000 | $1,092,842,000 | $1,105,573,000 |
| Selling And Marketing Expense | $643,547,000 | $588,507,000 | $566,066,000 | $524,505,000 |
| General And Administrative Expense | $404,794,000 | $442,291,000 | $335,825,000 | $326,248,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,059,464,000 | $887,867,000 | $845,042,000 | $679,089,000 |
| Net Interest Income | $-35,842,000 | $-18,506,000 | $-35,952,000 | $-38,793,000 |
| Interest Income | $3,010,000 | $12,699,000 | $5,629,000 | $1,065,000 |
| Normalized Income | $1,059,464,000 | $887,867,000 | $845,042,000 | $679,089,000 |
| Net Income From Continuing And Discontinued Operation | $1,059,464,000 | $887,867,000 | $845,042,000 | $679,089,000 |
| Total Operating Income As Reported | $1,360,031,000 | $1,128,337,000 | $1,097,128,000 | $898,765,000 |
| Net Income Common Stockholders | $1,059,464,000 | $887,867,000 | $845,042,000 | $679,089,000 |
| Net Income | $1,059,464,000 | $887,867,000 | $845,042,000 | $679,089,000 |
| Net Income Including Noncontrolling Interests | $1,059,464,000 | $887,867,000 | $845,042,000 | $679,089,000 |
| Net Income Continuous Operations | $1,059,464,000 | $887,867,000 | $845,042,000 | $679,089,000 |
| Pretax Income | $1,324,189,000 | $1,109,831,000 | $1,061,176,000 | $859,972,000 |
| Interest Income Non Operating | $3,010,000 | $12,699,000 | $5,629,000 | $1,065,000 |
| Operating Income | $1,360,031,000 | $1,128,337,000 | $1,097,128,000 | $898,765,000 |
| Gross Profit | $2,659,579,000 | $2,378,927,000 | $2,189,970,000 | $2,004,338,000 |
| Per Share | ||||
| Diluted EPS | $13.08 | $10.67 | $10.06 | $8.03 |
| Basic EPS | $13.17 | $10.77 | $10.17 | $8.12 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,508,224,000 | $1,270,972,000 | $1,217,665,000 | $1,011,730,000 |
| Reconciled Depreciation | $145,183,000 | $129,936,000 | $114,908,000 | $111,900,000 |
| EBITDA (Bullshit earnings) | $1,508,224,000 | $1,270,972,000 | $1,217,665,000 | $1,011,730,000 |
| EBIT | $1,363,041,000 | $1,141,036,000 | $1,102,757,000 | $899,830,000 |
| Diluted Average Shares | $81,025,000 | $83,246,000 | $83,978,000 | $84,600,000 |
| Basic Average Shares | $80,427,000 | $82,467,000 | $83,066,000 | $83,623,000 |
| Diluted NI Availto Com Stockholders | $1,059,464,000 | $887,867,000 | $845,042,000 | $679,089,000 |
| Tax Provision | $264,725,000 | $221,964,000 | $216,134,000 | $180,883,000 |
| Research And Development | $251,207,000 | $219,792,000 | $190,951,000 | $254,820,000 |
| Selling General And Administration | $1,048,341,000 | $1,030,798,000 | $901,891,000 | $850,753,000 |
| Other Gand A | $404,794,000 | $442,291,000 | $335,825,000 | $326,248,000 |
| Minority Interests | - | - | $0 | $0 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,081,536,000 | $1,078,537,000 | $1,034,069,000 | $149,270,000 |
| Total Assets | $3,350,759,000 | $3,293,443,000 | $3,259,925,000 | $2,746,765,000 |
| Total Non Current Assets | $1,936,932,000 | $1,893,546,000 | $1,764,671,000 | $1,645,288,000 |
| Other Non Current Assets | $219,219,000 | $178,664,000 | $165,014,000 | $50,838,000 |
| Non Current Deferred Assets | $27,871,000 | $125,630,000 | $107,364,000 | $162,420,000 |
| Non Current Deferred Taxes Assets | $27,871,000 | $125,630,000 | $107,364,000 | $55,215,000 |
| Non Current Accounts Receivable | $236,906,000 | $185,506,000 | $167,963,000 | $148,971,000 |
| Goodwill And Other Intangible Assets | $523,847,000 | $516,776,000 | $450,461,000 | $459,467,000 |
| Other Intangible Assets | $109,843,000 | $111,676,000 | $84,500,000 | $97,672,000 |
| Current Assets | $1,413,827,000 | $1,399,897,000 | $1,495,254,000 | $1,101,477,000 |
| Other Current Assets | $104,910,000 | $109,812,000 | $83,142,000 | $88,463,000 |
| Current Deferred Assets | $73,563,000 | $61,653,000 | $54,081,000 | $50,776,000 |
| Prepaid Assets | $57,900,000 | $58,626,000 | $48,370,000 | $41,742,000 |
| Inventory | $377,756,000 | $381,877,000 | $380,282,000 | $367,823,000 |
| Receivables | $693,191,000 | $561,316,000 | $529,528,000 | $490,903,000 |
| Other Receivables | $75,828,000 | $60,751,000 | $55,111,000 | $41,854,000 |
| Taxes Receivable | $64,985,000 | $26,990,000 | $16,972,000 | $48,430,000 |
| Accounts Receivable | $552,378,000 | $473,575,000 | $457,445,000 | $400,619,000 |
| Allowance For Doubtful Accounts Receivable | $-11,304,000 | $-12,585,000 | $-9,501,000 | $-8,265,000 |
| Gross Accounts Receivable | $563,682,000 | $486,160,000 | $466,946,000 | $408,884,000 |
| Cash Cash Equivalents And Short Term Investments | $180,070,000 | $288,266,000 | $453,932,000 | $112,546,000 |
| Cash And Cash Equivalents | $180,070,000 | $288,266,000 | $453,932,000 | $112,546,000 |
| Hedging Assets Current | - | - | - | $13,320,000 |
| Debt | ||||
| Net Debt | $667,767,000 | $579,307,000 | $493,948,000 | $1,235,823,000 |
| Total Debt | $976,062,000 | $986,948,000 | $1,067,353,000 | $1,470,033,000 |
| Long Term Debt And Capital Lease Obligation | $475,993,000 | $547,622,000 | $722,554,000 | $795,626,000 |
| Long Term Debt | $374,842,000 | $449,786,000 | $622,883,000 | $694,387,000 |
| Current Debt And Capital Lease Obligation | $500,069,000 | $439,326,000 | $344,799,000 | $674,407,000 |
| Current Debt | $472,995,000 | $417,787,000 | $324,997,000 | $653,982,000 |
| Other Current Borrowings | $74,995,000 | $167,787,000 | $74,997,000 | $74,982,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,745,376,000 | $1,698,130,000 | $1,775,395,000 | $2,138,028,000 |
| Total Non Current Liabilities Net Minority Interest | $596,562,000 | $630,214,000 | $823,848,000 | $902,225,000 |
| Tradeand Other Payables Non Current | $14,452,000 | $20,898,000 | $39,642,000 | $49,142,000 |
| Non Current Deferred Liabilities | $64,042,000 | $38,251,000 | $35,768,000 | $39,012,000 |
| Non Current Deferred Taxes Liabilities | $31,865,000 | $11,312,000 | $7,235,000 | $8,150,000 |
| Current Liabilities | $1,148,814,000 | $1,067,916,000 | $951,547,000 | $1,235,803,000 |
| Current Deferred Liabilities | $35,264,000 | $33,799,000 | $37,195,000 | $37,938,000 |
| Payables And Accrued Expenses | $401,037,000 | $420,208,000 | $395,178,000 | $380,464,000 |
| Payables | $199,076,000 | $176,463,000 | $197,196,000 | $158,768,000 |
| Total Tax Payable | $88,668,000 | $62,252,000 | $86,553,000 | $48,547,000 |
| Accounts Payable | $110,408,000 | $114,211,000 | $110,643,000 | $110,221,000 |
| Minimum Pension Liabilities | - | - | - | $-2,776,000 |
| Equity | ||||
| Common Stock Equity | $1,605,383,000 | $1,595,313,000 | $1,484,530,000 | $608,737,000 |
| Total Equity Gross Minority Interest | $1,605,383,000 | $1,595,313,000 | $1,484,530,000 | $608,737,000 |
| Stockholders Equity | $1,605,383,000 | $1,595,313,000 | $1,484,530,000 | $608,737,000 |
| Other Equity Interest | $6,094,000 | $5,885,000 | $5,530,000 | $5,182,000 |
| Gains Losses Not Affecting Retained Earnings | $-68,844,000 | $-93,645,000 | $-71,206,000 | $-77,796,000 |
| Other Equity Adjustments | $-68,844,000 | $-93,645,000 | $-71,206,000 | $-77,796,000 |
| Retained Earnings | $6,391,902,000 | $5,332,438,000 | $4,444,571,000 | $3,599,529,000 |
| Other | ||||
| Treasury Shares Number | $28,657,000 | $26,232,000 | $24,474,000 | $24,299,000 |
| Ordinary Shares Number | $79,712,000 | $81,604,000 | $83,032,000 | $82,894,000 |
| Share Issued | $108,369,000 | $107,836,000 | $107,506,000 | $107,193,000 |
| Tangible Book Value | $1,081,536,000 | $1,078,537,000 | $1,034,069,000 | $149,270,000 |
| Invested Capital | $2,453,220,000 | $2,462,886,000 | $2,432,410,000 | $1,957,106,000 |
| Working Capital | $265,013,000 | $331,981,000 | $543,707,000 | $-134,326,000 |
| Capital Lease Obligations | $128,225,000 | $119,375,000 | $119,473,000 | $121,664,000 |
| Total Capitalization | $1,980,225,000 | $2,045,099,000 | $2,107,413,000 | $1,303,124,000 |
| Treasury Stock | $6,561,356,000 | $5,334,012,000 | $4,474,681,000 | $4,392,112,000 |
| Additional Paid In Capital | $1,826,750,000 | $1,673,863,000 | $1,569,565,000 | $1,463,215,000 |
| Capital Stock | $10,837,000 | $10,784,000 | $10,751,000 | $10,719,000 |
| Common Stock | $10,837,000 | $10,784,000 | $10,751,000 | $10,719,000 |
| Non Current Accrued Expenses | $42,075,000 | $23,443,000 | $25,884,000 | $18,445,000 |
| Non Current Deferred Revenue | $32,177,000 | $26,939,000 | $28,533,000 | $30,862,000 |
| Long Term Capital Lease Obligation | $101,151,000 | $97,836,000 | $99,671,000 | $101,239,000 |
| Current Deferred Revenue | $35,264,000 | $33,799,000 | $37,195,000 | $37,938,000 |
| Current Capital Lease Obligation | $27,074,000 | $21,539,000 | $19,802,000 | $20,425,000 |
| Line Of Credit | $398,000,000 | $250,000,000 | $250,000,000 | $579,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $212,444,000 | $174,583,000 | $174,375,000 | $142,994,000 |
| Current Accrued Expenses | $201,961,000 | $243,745,000 | $197,982,000 | $221,696,000 |
| Investments And Advances | $58,481,000 | $57,718,000 | $56,193,000 | $55,500,000 |
| Other Investments | $58,481,000 | $57,718,000 | $56,193,000 | $55,500,000 |
| Goodwill | $414,004,000 | $405,100,000 | $365,961,000 | $361,795,000 |
| Net PPE | $870,608,000 | $829,252,000 | $817,676,000 | $768,092,000 |
| Accumulated Depreciation | $-925,698,000 | $-835,022,000 | $-784,817,000 | $-705,914,000 |
| Gross PPE | $1,796,306,000 | $1,664,274,000 | $1,602,493,000 | $1,474,006,000 |
| Leases | $125,304,000 | $119,844,000 | $116,347,000 | $107,251,000 |
| Construction In Progress | $68,982,000 | $67,144,000 | $79,059,000 | $97,310,000 |
| Other Properties | $123,228,000 | $116,129,000 | $115,499,000 | $118,618,000 |
| Machinery Furniture Equipment | $991,763,000 | $891,004,000 | $837,150,000 | $772,557,000 |
| Buildings And Improvements | $462,393,000 | $446,164,000 | $432,038,000 | $356,049,000 |
| Land And Improvements | $24,636,000 | $23,989,000 | $22,400,000 | $22,221,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $248,869,000 | $245,775,000 | $244,901,000 | $246,986,000 |
| Work In Process | $32,588,000 | $31,907,000 | $28,989,000 | $28,041,000 |
| Raw Materials | $96,299,000 | $104,195,000 | $106,392,000 | $92,796,000 |
| Minority Interest | - | - | - | $0 |
| Foreign Currency Translation Adjustments | - | - | - | $-87,691,000 |
| Unrealized Gain Loss | - | - | - | $-172,000 |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,043,579,000 | $798,079,000 | $772,879,000 | $384,146,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,181,805,000 | $929,001,000 | $906,510,000 | $542,984,000 |
| Cash Flow From Continuing Operating Activities | $1,181,805,000 | $929,001,000 | $906,510,000 | $542,984,000 |
| Investing Activities | ||||
| Capital Expenditure | $-138,226,000 | $-130,922,000 | $-133,631,000 | $-158,838,000 |
| Investing Cash Flow | $-136,239,000 | $-207,062,000 | $-125,254,000 | $-195,350,000 |
| Cash Flow From Continuing Investing Activities | $-136,239,000 | $-207,062,000 | $-125,254,000 | $-195,350,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-1,216,964,000 | $-837,034,000 | $-71,920,000 | $-819,711,000 |
| Financing Cash Flow | $-1,164,964,000 | $-878,073,000 | $-441,996,000 | $-370,936,000 |
| Cash Flow From Continuing Financing Activities | $-1,164,964,000 | $-878,073,000 | $-441,996,000 | $-370,936,000 |
| Net Other Financing Charges | $-10,977,000 | $-10,531,000 | $-13,110,000 | $-17,472,000 |
| Net Common Stock Issuance | $-1,216,964,000 | $-837,034,000 | $-71,920,000 | $-819,711,000 |
| Other | ||||
| Repayment Of Debt | $-428,385,000 | $-75,000,000 | $-75,000,000 | $-75,000,000 |
| Issuance Of Debt | $250,000,000 | $0 | $0 | $505,500,000 |
| End Cash Position | $180,070,000 | $288,266,000 | $453,932,000 | $112,546,000 |
| Beginning Cash Position | $288,266,000 | $453,932,000 | $112,546,000 | $144,454,000 |
| Effect Of Exchange Rate Changes | $11,202,000 | $-9,532,000 | $2,126,000 | $-8,606,000 |
| Changes In Cash | $-119,398,000 | $-156,134,000 | $339,260,000 | $-23,302,000 |
| Proceeds From Stock Option Exercised | $93,362,000 | $44,492,000 | $47,034,000 | $35,747,000 |
| Common Stock Payments | $-1,216,964,000 | $-837,034,000 | $-71,920,000 | $-819,711,000 |
| Net Issuance Payments Of Debt | $-30,385,000 | $-75,000,000 | $-404,000,000 | $430,500,000 |
| Net Short Term Debt Issuance | $148,000,000 | $0 | $-329,000,000 | $505,500,000 |
| Net Long Term Debt Issuance | $-178,385,000 | $-75,000,000 | $-75,000,000 | $-75,000,000 |
| Long Term Debt Payments | $-428,385,000 | $-75,000,000 | $-75,000,000 | $-75,000,000 |
| Long Term Debt Issuance | $250,000,000 | $0 | $0 | $0 |
| Net Investment Purchase And Sale | $2,743,000 | $1,558,000 | $8,377,000 | $0 |
| Sale Of Investment | $2,743,000 | $1,558,000 | $8,377,000 | $0 |
| Net Business Purchase And Sale | $-756,000 | $-77,698,000 | $0 | $-36,512,000 |
| Purchase Of Business | $0 | $-76,694,000 | $0 | $-11,512,000 |
| Net Intangibles Purchase And Sale | $-13,550,000 | $-10,000,000 | $0 | $-10,000,000 |
| Purchase Of Intangibles | $-13,550,000 | $-10,000,000 | $0 | $-10,000,000 |
| Net PPE Purchase And Sale | $-124,676,000 | $-120,922,000 | $-133,631,000 | $-148,838,000 |
| Purchase Of PPE | $-124,676,000 | $-120,922,000 | $-133,631,000 | $-148,838,000 |
| Change In Working Capital | $-227,514,000 | $-133,238,000 | $-72,429,000 | $-273,530,000 |
| Change In Other Working Capital | $-149,430,000 | $-85,043,000 | $10,650,000 | $-113,868,000 |
| Change In Payables And Accrued Expense | $-8,573,000 | $8,086,000 | $-557,000 | $3,467,000 |
| Change In Payable | $-8,573,000 | $8,086,000 | $-557,000 | $3,467,000 |
| Change In Account Payable | $-8,573,000 | $8,086,000 | $-557,000 | $3,467,000 |
| Change In Inventory | $-789,000 | $-28,001,000 | $-28,651,000 | $-121,731,000 |
| Change In Receivables | $-68,722,000 | $-28,280,000 | $-53,871,000 | $-41,398,000 |
| Changes In Account Receivables | $-68,722,000 | $-28,280,000 | $-53,871,000 | $-41,398,000 |
| Other Non Cash Items | $5,026,000 | $1,468,000 | $2,004,000 | $2,645,000 |
| Stock Based Compensation | $60,013,000 | $60,295,000 | $59,739,000 | $49,770,000 |
| Provisionand Write Offof Assets | $8,429,000 | $6,867,000 | $5,552,000 | $5,829,000 |
| Deferred Tax | $131,204,000 | $-24,194,000 | $-48,306,000 | $-35,065,000 |
| Deferred Income Tax | $131,204,000 | $-24,194,000 | $-48,306,000 | $-35,065,000 |
| Depreciation Amortization Depletion | $145,183,000 | $129,936,000 | $114,908,000 | $111,900,000 |
| Depreciation And Amortization | $145,183,000 | $129,936,000 | $114,908,000 | $111,900,000 |
| Net Income From Continuing Operations | $1,059,464,000 | $887,867,000 | $845,042,000 | $679,089,000 |
| Asset Impairment Charge | - | $250,000 | $1,484,000 | $2,346,000 |
| Short Term Debt Issuance | - | - | - | $505,500,000 |
Fetched: 2026-06-23